DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Hetlioz (Tasimelteon) - Summary

 
 



HETLIOZ SUMMARY

HETLIOZ (tasimelteon) is a melatonin receptor agonist.

HETLIOZ is indicated for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24).


See all Hetlioz indications & dosage >>

NEWS HIGHLIGHTS

Published Studies Related to Hetlioz (Tasimelteon)

Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials. [2009]
associated with shifted sleep and wake time... INTERPRETATION: After an abrupt advance in sleep time, tasimelteon improved sleep

Tasimelteon: a melatonin receptor agonist for non-24-hour sleep-wake disorder. [2014]
CONCLUSION: Tasimelteon improves sleep initiation and maintenance in patients

more studies >>


Page last updated: 2015-08-10

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017